AlphAIalphai — Financial news for AI agents
manilatimes.netJUN 41 min read$WGO

Winnebago Industries to announce third quarter fiscal 2026 financial results on June 25, 2026

Winnebago Industries (NYSE: WGO) said it will release its third-quarter fiscal 2026 financial results before the NYSE opens on June 25, 2026. The company will host a conference call at 9:00 a.m. CT with CEO Michael Happe and CFO Bryan Hughes. The call will be available via the company’s investor website and archived for up to one year.

Original reporting
manilatimes.net
Published Jun 4, 2026, 6:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 6:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Winnebago Industries to announce third quarter fiscal 2026 financial results on June 25, 2026 — source image
Source · manilatimes.net
Decision brief

The 30-second read

$WGONeutralMed
01

Why it matters

This sets a concrete event date for earnings-driven volatility and for adjusting hedges/position sizing into the print; however, it does not introduce any new financial or guidance information.

02

Market read

Primary relevance is timing: a scheduled earnings catalyst for WGO with potential for pre-earnings positioning and post-release repricing.

03

What to watch

Traders should focus on what management may emphasize in the call (margins, order trends, backlog, incentives) since the article provides no qualitative signals.

Relevance 7/10Novelty 4/10Timing: Ahead of the June 25, 2026 pre-market Q3 fiscal 2026 results release.

Background

Winnebago Industries will report third quarter fiscal 2026 results before NYSE opening on June 25, 2026, with a conference call at 9:00 a.m. CT.

Company-level read

Ticker impact

$WGONeutralMedium confidence
Context

Winnebago Industries scheduled its Q3 fiscal 2026 results for June 25, setting a clear near-term catalyst for WGO positioning.

Expected impact

Low-to-moderate volatility risk into the June 25 pre-market release; direction depends on the upcoming quarter’s results and guidance.

Evidence & confidence

No financial figures, guidance, or operational changes are provided—only the earnings date/time and call details, which typically influence options/positioning and short-term volatility.

Market effects

Sector

May modestly affect sentiment for US outdoor/leisure vehicle demand expectations around the earnings calendar, but no sector-wide data is provided.

Regional

Limited; the update is company-specific with no regional macro linkage mentioned.

Global

Low; no international demand, supply chain, or FX commentary is included.

Counterpoint

What could challenge this read

Because the release date is already foreseeable via typical investor calendars, the incremental trading edge may be small versus broader earnings expectations.

Key entities

  • company
    Winnebago Industries, Inc.

    Outdoor recreation vehicle manufacturer scheduled to release Q3 fiscal 2026 results on June 25, 2026.

  • executive
    Michael Happe

    President and CEO hosting the earnings call.

  • executive
    Bryan Hughes

    Senior VP and CFO hosting the earnings call.

Read at source← All news

Related articles

JUN 25
$WGOMed

WINNEBAGO INDUSTRIES INC (WGO): Results of Operations and Financial Condition

WINNEBAGO INDUSTRIES INC (WGO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exh9912026q3earningsrelease.htm EX-99.1 Document Exhibit 99.1 News Release WINNEBAGO INDUSTRIES REPORTS THIRD QUARTER FISCAL 2026 RESULTS -- Motorhome RV Sales, Profit Dollars and Profit Margins Improved Meaningfully Year Over Year -- -- Winnebago Towables Improved Shar

SEC EDGAR 8-K6 min
JUN 25
$WGOMed

Winnebago Industries Reports Third Quarter Fiscal 2026 Results

Winnebago Industries (NYSE: WGO) reported fiscal 2026 third-quarter results ended May 30, 2026. Net revenues fell to $698.7M from $775.1M; gross profit to $94.9M (13.6% margin). Net income was $14.5M ($0.51 diluted; adjusted EPS $0.66). Adjusted EBITDA was $37.8M. The company cited improved Motorhome RV performance, muted Towables demand, and Barletta market-share gains, and said it updated fiscal 2026 guidance.

manilatimes.net6 min
MAY 28
$WGOMedAI 8/10

White Gold Corp. Commences 2026 Exploration Program Designed to Further Increase Known Gold Resources and Make New Discoveries on its District Scale Land Package in Yukon, Canada

White Gold Corp. says it has started a fully funded 2026 exploration program on its district-scale land package in Yukon, Canada, supported by partners including Agnico Eagle. The program targets resource growth at the Golden Saddle, Arc, Ryan’s Surprise and VG deposits, all open for expansion, and includes the company’s largest diamond drilling campaign. White Gold is also advancing a maiden Preliminary Economic Assessment expected soon.

torontotelegraph.com4 min
MAY 28
$WGOMedAI 8/10

White Gold Corp. Commences 2026 Exploration Program Designed to Further Increase Known Gold Resources and Make New Discoveries on its District Scale Land Package in Yukon, Canada

White Gold Corp. says it has started its fully funded 2026 Yukon exploration program on its district-scale land package, targeting resource growth and new discoveries around the Golden Saddle, Arc, Ryan’s Surprise and VG deposits, all described as open for expansion. The company, with partners including Agnico Eagle, plans its largest diamond drilling campaign. A maiden Preliminary Economic Assessment is expected soon.

hawaiitelegraph.com4 min
AUG 8
$LLYMedAI 8/10

Eli Lilly and Company Q2 Earnings Call Highlights

Eli Lilly (LLY) reported Q2 U.S. revenue up 33% led by ZEPBOUND and MOUNJARO volume, while U.S. price fell 3% (9% excluding rebate and discount estimate changes). International revenue rose in constant currency, with MOUNJARO a key driver. Lilly raised its 2026 revenue outlook to $85B-$87B and guided non-GAAP EPS $35.50-$36.50. It also discussed Medicare GLP-1 coverage expansion and retatrutide Phase III results.

yahoo.com7 min